Virendra Joshi, MD
Gastroenterology · New Orleans, LANPI 1295828507
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,433 of the $16,042 with a category attached, or 71.3%. 20 manufacturers reported payments, led by Conmed Corporation at 38.8% of the total. Reporting peaked in 2019 at $8,382 and has fallen 97.9% since, to $175 in 2025.
Across 82 payments — averaging $195.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conmed Corporation$6K
- Ferring Pharmaceuticals Inc.$4K
- Pentax Of America, Inc.$2K
- Merit Medical Systems Inc$2K
- Cook Medical LLC$501
- Boston Scientific$309
- plus $1K from 14 others
Across 17 payments — averaging $3809.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ironwood Pharmaceuticals, Inc$33K
- Takeda Pharmaceuticals U.S.A., Inc.$21K
- Mauna Kea Technologies, Inc.$10K
- Pentax Of America, Inc.$1K
What the payments were for
- Consulting fees$11,43371%
- Travel & lodging$1,1687%
- Food & beverage$3,36421%
- Education$240%
- Entertainment$540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conmed Corporation | 2 | $6,229 |
| Ferring Pharmaceuticals Inc. | 2 | $3,847 |
| Pentax Of America, Inc. | 25 | $2,210 |
| Merit Medical Systems Inc | 3 | $1,678 |
| Cook Medical LLC | 9 | $501 |
| Boston Scientific | 3 | $309 |
| Mauna Kea Technologies, Inc. | 5 | $241 |
| AbbVie | 11 | $199 |
| Bristol Myers Squibb | 6 | $140 |
| Medtronic | 1 | $121 |
| Fresenius Kabi USA, LLC | 2 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $111 |
| Olympus America Inc. | 1 | $94 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| Celltrion USA Inc. | 2 | $55 |
| Ardelyx, Inc. | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Biocon Biologics Inc | 1 | $18 |
| Gilead | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYSTEM 5000$6,043
- REBYOTA$3,815
- NvisionVLE Imaging System$1,575
- C2 Cryoballoon$521
- CryoBalloon$273
- PENTAX Medical$244
- CONMED BILIARY$186
- Hemospray$175
- EchoTip$140
- INSPIRA$122
- C2 CryoBalloon Focal Controller$122
- GI Genius$121
- Idacio$103
How this compares
$16,042 in reported general payments places this provider in the 85th percentile of 254 gastroenterology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 56 | $117,291 |
| LinzessLinaclotide | 57 | $44,250 |
| Sucralfate | 97 | $10,417 |
| Ursodiol | 25 | $5,358 |
| Omeprazole | 299 | $3,989 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 15 | $2,645 |
| Dicyclomine Hcl | 77 | $2,305 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 94 | $1,261 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 33 | $556 |
| Lactulose | 58 | $547 |
| Ondansetron OdtOndansetron | 47 | $507 |
| Clarithromycin | 13 | $414 |
| Pantoprazole Sodium | 32 | $337 |
| Metronidazole | 12 | $190 |
| Metoclopramide Hcl | 28 | $99 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $199 | $161,542113 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $3,847 | $2,64515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 254 gastroenterology providers in Louisiana.
Other gastroenterology in New Orleans
- Sarah GloverNew Orleans$274K
- Nisha LoganantharajNew Orleans$173K
- Shamita ShahNew Orleans$114K
- Vivek HuilgolNew Orleans$37K
- Arnab RayNew Orleans$26K
- Janak ShahNew Orleans$18K
- Stephen LandreneauNew Orleans$17K
- Parth ParekhNew Orleans$10K
- Jonathon ChapmanBaton Rouge$998K
- Conar FittonKenner$955K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.